After winning an early deal on XO1, the virtual biotech gang gets back together for SuperX
A little less than two years after J&J swooped in to snag the preclinical antithrombin drug at XO1 in the UK, the virtual team …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
